The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.00
Bid: 12.00
Ask: 14.00
Change: 0.00 (0.00%)
Spread: 2.00 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 13.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Feb 2011 07:00

RNS Number : 8989A
Carclo plc
09 February 2011
 



9 February 2011

 

Carclo plc

("Carclo" or "the Group")

 

Interim Management Statement

 

The Group continues to trade broadly in line with the board's expectations for the full year and our financial position remains strong.

 

In the Technical Plastics division operating profits for the full year are expected to be more than 10% up on the prior year. Growth in our medical and LED optics businesses continues to be good, although in recent weeks we have seen some order cancellations in optics and some evidence of inventory management by our global teletronic customers. We anticipate that these are temporary issues and the division is set to enjoy a solid last quarter. Technical Plastics is expected to make further progress in profitability in the next financial year as a result of continued growth in its medical and optical businesses.

 

In the Precision Products division trading in the Group's aerospace business is stable and ahead of the prior year. Wipac is having a stronger second half benefiting from the ramp up in production on a number of supercar lighting programmes. Production efficiency continues to improve and Wipac is expected to deliver a significant boost to profitability in the next financial year. In recent weeks Wipac has won design nominations on two new supercar lighting programmes. The profit on these contracts will mainly be recognised in the next financial year and tooling profits in the current year will be slightly lower than planned.

 

Conductive Inkjet Technology ("CIT") has made further significant progress especially with its fine line technology. The Cambridge facility development for the touch screen production line is nearing completion and the pilot line upgrade to integrate our Gen 3 chemistry is on target. We expect volume production to start during the second half of the 2011 calendar year. The revenues that CIT will generate from its agreement with Atmel Corporation on touch screens are expected to be substantial and material in the context of Carclo's prospective revenue and profit growth.

 

- ENDS -

 

Enquiries:

Carclo plc

01924 268040

Ian Williamson, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat / Clare Thomas

 

Notes to editors

 

·; Carclo plc is a global supplier of technical plastic components. It is a public company whose shares are quoted on the London Stock Exchange.

 

·; Two thirds of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

·; One third of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries.

 

·; Carclo's strategy is to develop new technologies and products to drive future growth.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUCUPUPGGMR
Date   Source Headline
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.